Cannabinoids CB2 Receptors, One New Promising Drug Target for Chronic and Degenerative Pain Conditions in Equine Veterinary Patients
- 1 February 2020
- journal article
- review article
- Published by Elsevier in Journal of Equine Veterinary Science
- Vol. 85, 102880
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Supply and demand for endocannabinoidsTrends in Neurosciences, 2011
- Functionally selective cannabinoid receptor signalling: Therapeutic implications and opportunitiesBiochemical Pharmacology, 2010
- Cannabinoids: A New Group of Agonists of PPARsPPAR Research, 2007
- Novel cannabinoid receptorsBritish Journal of Pharmacology, 2007
- A brief history of cannabinoid and endocannabinoid pharmacology as inspired by the work of British scientistsTrends in Pharmacological Sciences, 2006
- Anandamide as an intracellular messenger regulating ion channel activityProstaglandins & Other Lipid Mediators, 2005
- The molecular logic of endocannabinoid signallingNature Reviews Neuroscience, 2003
- A role for monoglyceride lipase in 2-arachidonoylglycerol inactivationChemistry and Physics of Lipids, 2002
- Cannabinoid-mediated Inhibition of Inducible Nitric Oxide Production by Rat Microglial Cells: Evidence for CB1 Receptor Participation2001
- Cannabinoid Receptor Localization in Brain: Relationship to Motor and Reward SystemsAnnals of the New York Academy of Sciences, 1992